# Dose-range Finding Treosulfan-based Conditioning

> **NCT01063647** · PHASE1,PHASE2 · COMPLETED · sponsor: **medac GmbH** · enrollment: 56 (actual)

## Conditions studied

- Hematological Malignancies

## Interventions

- **DRUG:** Treosulfan
- **DRUG:** Treosulfan
- **DRUG:** Treosulfan

## Key facts

- **NCT ID:** NCT01063647
- **Lead sponsor:** medac GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2005-06
- **Final completion:** 2006-06
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01063647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01063647, "Dose-range Finding Treosulfan-based Conditioning". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01063647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*